TRE-515
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TRE-515, covering 2025-09-12 to 2025-09-12. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors [Phase 1]